Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ovarian Cancer Liquid Biopsy for Early Assessment & Detection (OC-LEAD)

NCT07764744 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT07764744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07764744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ovarian Cancer Liquid Biopsy for Early Assessment & Detection (OC-LEAD)
Lead sponsor
Weill Medical College of Cornell University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
July 31, 2039
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brca 1 gene mutation, brca 2 gene mutation, early detection of ovarian cancer, ovarian neoplasms, serous tubal intraepithelial carcinoma